botensilimab
Generic: AGEN1181·Code: AGEN1181
botensilimab: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| AGENUS INC (AGEN) | Phase 1 |
Clinical Trials (1)
Phase 2 Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial
Frequently asked questions
Who is developing botensilimab?
botensilimab is being developed by AGENUS INC.
How many clinical trials involve botensilimab?
BioSniper tracks 1 clinical trial involving botensilimab.
Get deeper analysis on botensilimab
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis